BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31611976)

  • 21. Co-expression Network Analysis of Biomarkers for Adrenocortical Carcinoma.
    Yuan L; Qian G; Chen L; Wu CL; Dan HC; Xiao Y; Wang X
    Front Genet; 2018; 9():328. PubMed ID: 30158955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis.
    Zou Z; Gan S; Liu S; Li R; Huang J
    Oncol Lett; 2019 Jul; 18(1):916-926. PubMed ID: 31289570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
    Wang M; Wang L; Wu S; Zhou D; Wang X
    Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis.
    Zeng X; Shi G; He Q; Zhu P
    Sci Rep; 2021 Oct; 11(1):20799. PubMed ID: 34675265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
    Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
    Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
    Chen W; Zhu S; Zhang Y; Xiao J; Tian D
    Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Key Genes and Related Drugs of Adrenocortical Carcinoma by Integrated Bioinformatics Analysis.
    Wei JB; Zeng XC; Ji KR; Zhang LY; Chen XM
    Horm Metab Res; 2023 Dec; ():. PubMed ID: 38109896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
    Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
    Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
    Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
    Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key genes involved in the metastasis of clear cell renal cell carcinoma.
    Wei W; Lv Y; Gan Z; Zhang Y; Han X; Xu Z
    Oncol Lett; 2019 May; 17(5):4321-4328. PubMed ID: 30988807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
    Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
    BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of four hub genes associated with adrenocortical carcinoma progression by WGCNA.
    Xia WX; Yu Q; Li GH; Liu YW; Xiao FH; Yang LQ; Rahman ZU; Wang HT; Kong QP
    PeerJ; 2019; 7():e6555. PubMed ID: 30886771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.
    Lv S; Xu X; Wu Z
    Oncol Lett; 2019 Dec; 18(6):6679-6689. PubMed ID: 31807178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of hub genes and pathways in glioblastoma by bioinformatics analysis.
    Yang S; Gao K; Li W
    Oncol Lett; 2019 Jan; 17(1):1035-1041. PubMed ID: 30655863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.